biuro@scopefluidics.com +48 22 376 21 14
enpl
biuro@scopefluidics.com +48 22 376 21 14
biuro@scopefluidics.com +48 22 376 21 14

Day

April 2, 2021
02
Apr

Scope Fluidics completes clinical trials of a rapid PCR|ONE genetic test for detecting Staphylococcus aureus and its drug-resistant variants (MRSA)

02.04.2021
Read More

Text Widget

Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada magna mollis euismod.

Recent Comments

    Tag Cloud

    home